The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
External validation of the ARCAD nomogram in a real-world cohort of patients with stage IV colorectal cancer (CRC).
 
James Yu
No Relationships to Disclose
 
Jiannong Li
No Relationships to Disclose
 
Michael Schell
No Relationships to Disclose
 
Pablo Gonzalez Ginestet
No Relationships to Disclose
 
John Raymond Zalcberg
Leadership - ICON Group; Lipotek; Praxis Therapeutics
Stock and Other Ownership Interests - Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Madrigal Pharmaceuticals; Moderna Therapeutics; Novavax; Opthea; Orphazyme; Teladoc; Twist Bioscience; UniQure; Zogenix
Honoraria - Gilead Sciences; MSD Oncology; Viatris
Consulting or Advisory Role - 1Globe Health Institute; Alloplex Biotherapeutics Inc; Center for Emerging & Neglected Diseases (CEND); Deciphera; FivePHusion; Genor BioPharma; Merck Sharp & Dohme; NOUS Group; Novotech; Oncology Republic; Revolution Medicines; Specialised Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst); Servier (Inst)
Travel, Accommodations, Expenses - ICON Group; MSD Oncology; Praxis Therapeutics
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Ian Marschner
No Relationships to Disclose
 
Richard D. Kim
Consulting or Advisory Role - Abbvie; AstraZeneca; Exelixis; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte
 
Katrin Marie Sjoquist
Honoraria - BMS; Merck; MSD; Novotech (Inst); Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech